CogGen, founded in 2017, aims to remove obstacles for children facing learning disabilities by providing pre-symptomatic genetic screening for dyslexia, SLI, and SSD. Their proprietary technology allows for early intervention in reading-age children, resulting in improved academic performance and long-term quality of life. CogGen offers a saliva sample collection kit for their non-invasive test, which aims to identify pre-symptomatic risk for common reading and learning disabilities.